DelphX Announces Closing of Additional Units in Non-Brokered Unit Private Placement, and Grant of Stock Options

Rhea-AI Summary

DelphX Capital Markets (OTCQB: DPXCF) has completed an additional issuance of 1,000,000 units at C$0.05 per unit, raising C$50,000 in a non-brokered private placement. This brings the total placement to 6,000,000 units for C$300,000. Each unit includes one common share and one warrant exercisable at C$0.08 for two years.

Insiders participated by subscribing for 1,000,000 units. The company also granted 1,800,000 stock options with a two-year maturity, exercisable at C$0.08 per share. The private placement proceeds will be used for general corporate purposes.

Positive

• Raised additional C$50,000 through private placement, bringing total to C$300,000
• Insider participation demonstrates management confidence
• Stock options grant aligns management interests with shareholders

Negative

• Significant dilution through unit offering at C$0.05 per unit
• Additional dilution potential from warrants and stock options at C$0.08
• Relatively small capital raise may indicate limited investor interest

Toronto, Ontario--(Newsfile Corp. - September 9, 2025) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products, announces that further to its news release dated August 29, 2025 with respect to its non-brokered private placement, it has issued an additional 1,000,000 units (the "Units") at a subscription price of C$0.05 per Unit, for additional gross proceeds of C$50,000 ("the Offering"). Completion of the additional issuance will result in the Company having issued an aggregate of 6,000,000 Units for aggregate proceeds of $300,000 in the private placement. Each Unit consists of one common share ("Common Share") and one Common Share purchase warrant ("Warrant"). Each Warrant entitles the holder to purchase one Common Share at a price of $0.08, for a period of two years from the date of issuance.

Insiders participated in the Offering, subscribing for 1,000,000 Units, and as a result the Offering is considered a "related party transaction" within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101") and TSXV Policy 5.9 – Protection of Minority Security Holders in Special Transactions. However, DelphX has relied on the exemptions from the formal valuation and minority approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101 in respect of related party participation, as neither the fair market value of the securities issued to insiders nor the cash consideration paid for such securities exceeded 25% of DelphX's market capitalization. A material change report was not filed more than 21 days prior to closing of the Offering as the participation of insiders in the Offering and the extent of such participation was not finalized until shortly prior to the completion of the Offering.

The Offering has been conditionally accepted by the TSX Venture Exchange, and completion of the Offering is subject to the fulfilment of certain customary requirements and final acceptance by the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance.

DelphX intends to use the net proceeds from the Offering in connection with general corporate purposes.

DelphX also announces that its Board of Directors has approved the grant of 1,800,000 stock options (the "Options") to eligible participants under its stock option plan (the "Plan"). The Options have a two-year maturity and are exercisable for common shares of DelphX at an exercise price of $0.08 per common share, all in accordance with the Plan.

About DelphX Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

• Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;

• Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.

For more information about DelphX, please visit www.delphx.com.

George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com
(718) 509-2160

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/265781

FAQ

How much did DelphX (DPXCF) raise in its latest private placement?

DelphX raised an additional C$50,000 through the issuance of 1,000,000 units at C$0.05 per unit, bringing the total placement to C$300,000.

What are the terms of DelphX's private placement units?

Each unit consists of one common share and one warrant, with warrants exercisable at C$0.08 for a period of two years from issuance.

How many stock options did DelphX grant in September 2025?

DelphX granted 1,800,000 stock options with a two-year maturity, exercisable at C$0.08 per common share.

What is the insider participation in DelphX's private placement?

Insiders participated by subscribing for 1,000,000 units, representing a significant portion of the additional issuance.

How will DelphX use the proceeds from the private placement?

DelphX intends to use the net proceeds from the offering for general corporate purposes.